; and (III) how its specific assignment of a grade to a product or service may affect coverage and access to such product or service under Federal programs and private health insurance coverage. (v) Dissemination of evidence-based recommendations The Task Force shall publish and disseminate the evidence-based recommendations after consultation with the following: (I) Relevant patient organizations. (II) Providers of clinical services, including community-based providers and specialty physicians. (III) The Department of Veterans Affairs, the Centers for Medicare & Medicaid Services, and the Centers for Disease Control and Prevention. (D) Grading system Subject to subparagraph (E), in publishing recommendation statements (as that term is used for purposes of section 7 of the procedure manual referred to in clause (i)), the Task Force shall grade products and services consistent with the following: (i) Grade A The Task Force shall assign a product or service Grade A if the Task Force concludes that the current evidence is sufficient to assess the balance of benefits and risks of the product or service, and, on the basis of such evidence, recommends the product or service and determines that there is high certainty that the net benefit from the product or service is substantial. (ii) Grade B The Task Force shall assign a product or service Grade B if the Task Force concludes that the current evidence is sufficient to assess the balance of benefits and risks of the product or service, and, on the basis of such evidence, recommends the product or service and determines that there is high certainty that the net benefit of the product or service is moderate or there is moderate certainty that the net benefit of the product or service is moderate to substantial. (iii) Grade C The Task Force shall assign a product or service Grade C if the Task Force concludes that— (I) the current evidence is sufficient to assess the balance of benefits and risks of the product or service